CAS 108736-35-2 Lanreotide

Send Inquiry
CAS 108736-35-2 Lanreotide
Details
CAS: 108736-35-2
Sequence: β-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH₂ (cyclized via Cys2-Cys7 disulfide bridge)
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Pharmaceutical Peptides / Long-acting Somatostatin Analog
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 108736-35-2 lanreotide in China, also supports custom service. Welcome to wholesale bulk high quality cas 108736-35-2 lanreotide from our factory. Contact us for more details.

 

Product name CAS:108736-35-2:Lanreotide
Description Lanreotide is a long-acting somatostatin SSTR2 receptor highly selective agonist. Cyclic peptide backbone enhances metabolic stability, and self-assembles into hydrogel at high concentration for sustained release. Applied in mechanism research of acromegaly, neuroendocrine tumors and hormone secretion disorders.
Peptide purity (HPLC, %) 95%/98%/99%
Molecular formula C₅₄H₆₉N₁₁O₁₀S₂ (free base)
Molecular weight (Da) 1096.33
Salt form Acetate

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
Lanreotide Lanreotide; BIM-23014; CAS 108736-35-2; SSTR2 agonist Highly selective SSTR2 agonist,Long-acting sustained release,Acromegaly study,Neuroendocrine tumor research,Hormone secretion suppression,Self-assembling hydrogel β-Naphthylalanine-cysteine-tyrosine-D-tryptophan-lysine-valine-cysteine-threoninamide (cyclized via Cys2-Cys7 disulfide bridge) C₅₄H₆₉N₁₁O₁₀S₂ (free base) 1095.46 1096.33 Free amine, with β-Nal unnatural amino acid Amidation 8

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-LAN001 white powder Store at -20℃, strictly protected from light, sealed and dry, aliquoted; avoid repeated freeze-thaw cycles. Strictly prohibited from reducing agents Solid powder stable for 2 years at 2-8℃ sealed and dry; prepare low-concentration solutions freshly before use Stable for 72 h at 4℃; stable for 1 month at -20℃ in aliquots. Good water solubility at low concentration; self-assembles into hydrogel at high concentration. Disulfide bridge is highly sensitive to strong reducing agents and prone to cleavage. Light-sensitive and easily degraded, strict light protection required Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-LAN001 Highly selective SSTR2 agonist with self-assembling hydrogel for long-acting sustained release, inhibits hormone secretion and tumor proliferation Lanreotide is a second-generation somatostatin analog with an eight-amino acid cyclic backbone. β-Naphthylalanine substitution enhances receptor affinity and metabolic stability, and C-terminal amidation further prolongs half-life. It binds with high selectivity to somatostatin SSTR2 receptor, inhibits adenylate cyclase to reduce cAMP levels, potently suppresses secretion of multiple hormones including growth hormone, insulin and glucagon, and simultaneously inhibits tumor cell proliferation and constricts tumor blood vessels. Its unique molecular structure enables self-assembly into nanofiber hydrogel in high-concentration aqueous solution, with slow release after subcutaneous injection and half-life of several days for long-acting therapy. It serves as a core tool peptide for acromegaly, neuroendocrine tumor and hormone secretion disorder mechanism research, as well as long-acting somatostatin drug development. Acromegaly research,Neuroendocrine tumor research,Hormone secretion regulation research,Self-assembling hydrogel study,Long-acting peptide drug development,Tumor proliferation inhibition research Somatostatin Receptor 2 (SSTR2); cAMP/PKA signaling pathway; Hormone secretion regulatory pathway; Self-assembling nanofiber formation mechanism

Hot Tags: cas 108736-35-2 lanreotide, China cas 108736-35-2 lanreotide manufacturers, suppliers, factory, 1415456-99-3, 910463-68-2, BPC 157, Cagrilintide, CAS 137525 51 0, CAS 1566590 77 9

Send Inquiry